0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NK Cell Therapy Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-12I12998
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global NK Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global NK Cell Therapy Market Research Report 2026

Code: QYRE-Auto-12I12998
Report
2026-03-03
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NK Cell Therapy Market Size

The global NK Cell Therapy market was valued at US$ 576 million in 2025 and is anticipated to reach US$ 1824 million by 2032, at a CAGR of 18.2% from 2026 to 2032.

NK Cell Therapy Market

NK Cell Therapy Market

Natural Killer (NK) cell therapy is an immunotherapy that utilizes NK cells, a type of cytotoxic lymphocyte, to target and destroy cancer cells or virus-infected cells. Unlike T cells, NK cells can recognize and eliminate abnormal cells without prior sensitization, making them a valuable tool for innate immune response-based treatments. NK cells can be derived from peripheral blood, umbilical cord blood, induced pluripotent stem cells, or established NK cell lines, and are often modified or expanded ex vivo before being infused into patients. This therapy is primarily being developed for oncology, with applications in hematologic malignancies and solid tumors, as well as in infectious diseases.
The NK cell therapy market is rapidly emerging as a promising segment within the broader cell therapy landscape. It is gaining momentum due to its potential to overcome some of the limitations associated with other immunotherapies, such as CAR-T therapy, including lower risks of cytokine release syndrome and graft-versus-host disease. NK cell therapies are under extensive clinical investigation worldwide, with numerous preclinical and clinical trials targeting leukemia, lymphoma, and solid tumors. Companies and research institutions are actively exploring genetic modifications, such as CAR-NK cells, to enhance efficacy and specificity. Favorable regulatory trends in regions like the U.S., Europe, and Asia are contributing to faster development pathways and commercialization opportunities. Additionally, collaborations between biotech firms, pharmaceutical companies, and academic centers are accelerating innovation and expanding the therapeutic pipeline. Despite challenges in manufacturing scalability and persistence of NK cells in vivo, the market outlook remains positive. Investors are showing strong interest, and the next decade is expected to witness significant progress in both technical development and clinical adoption of NK cell therapies.
This report delivers a comprehensive overview of the global NK Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NK Cell Therapy. The NK Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global NK Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist NK Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of NK Cell Therapy Market Report

Report Metric Details
Report Name NK Cell Therapy Market
Accounted market size in 2025 US$ 576 million
Forecasted market size in 2032 US$ 1824 million
CAGR 18.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • NK Cell Therapy
  • CAR-NK Cell Therapy
Segment by Application
  • Cancer
  • Infectious Diseases
  • Gastrointestinal Diseases
  • Beauty and Anti-Aging
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nektar Therapeutics, ImmunityBio, Inc, GC Cell, Affimed, Innate Pharma SA, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Fortress Biotech, Nkure
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for NK Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is NK Cell Therapy Market growing?

Ans: The NK Cell Therapy Market witnessing a CAGR of 18.2% during the forecast period 2026-2032.

What is the NK Cell Therapy Market size in 2032?

Ans: The NK Cell Therapy Market size in 2032 will be US$ 1824 million.

Who are the main players in the NK Cell Therapy Market report?

Ans: The main players in the NK Cell Therapy Market are Nektar Therapeutics, ImmunityBio, Inc, GC Cell, Affimed, Innate Pharma SA, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Fortress Biotech, Nkure

What are the Application segmentation covered in the NK Cell Therapy Market report?

Ans: The Applications covered in the NK Cell Therapy Market report are Cancer, Infectious Diseases, Gastrointestinal Diseases, Beauty and Anti-Aging, Others

What are the Type segmentation covered in the NK Cell Therapy Market report?

Ans: The Types covered in the NK Cell Therapy Market report are NK Cell Therapy, CAR-NK Cell Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NK Cell Therapy
1.2.3 CAR-NK Cell Therapy
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Gastrointestinal Diseases
1.3.5 Beauty and Anti-Aging
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2021–2032)
2.2 Global NK Cell Therapy Growth Trends by Region
2.2.1 Global NK Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 NK Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top NK Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2025
3.5 Global Key Players of NK Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of NK Cell Therapy, Products and Applications
3.7 Global Key Players of NK Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2027–2032)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America NK Cell Therapy Market Size (2021–2032)
6.2 North America NK Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America NK Cell Therapy Market Size by Country (2021–2026)
6.4 North America NK Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2021–2032)
7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe NK Cell Therapy Market Size by Country (2021–2026)
7.4 Europe NK Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2021–2032)
9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America NK Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America NK Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2021–2026)
11.1.5 Nektar Therapeutics Recent Development
11.2 ImmunityBio, Inc
11.2.1 ImmunityBio, Inc Company Details
11.2.2 ImmunityBio, Inc Business Overview
11.2.3 ImmunityBio, Inc NK Cell Therapy Introduction
11.2.4 ImmunityBio, Inc Revenue in NK Cell Therapy Business (2021–2026)
11.2.5 ImmunityBio, Inc Recent Development
11.3 GC Cell
11.3.1 GC Cell Company Details
11.3.2 GC Cell Business Overview
11.3.3 GC Cell NK Cell Therapy Introduction
11.3.4 GC Cell Revenue in NK Cell Therapy Business (2021–2026)
11.3.5 GC Cell Recent Development
11.4 Affimed
11.4.1 Affimed Company Details
11.4.2 Affimed Business Overview
11.4.3 Affimed NK Cell Therapy Introduction
11.4.4 Affimed Revenue in NK Cell Therapy Business (2021–2026)
11.4.5 Affimed Recent Development
11.5 Innate Pharma SA
11.5.1 Innate Pharma SA Company Details
11.5.2 Innate Pharma SA Business Overview
11.5.3 Innate Pharma SA NK Cell Therapy Introduction
11.5.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2021–2026)
11.5.5 Innate Pharma SA Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Details
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics NK Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2021–2026)
11.6.5 Fate Therapeutics Recent Development
11.7 Glycostem Therapeutics
11.7.1 Glycostem Therapeutics Company Details
11.7.2 Glycostem Therapeutics Business Overview
11.7.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.7.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2021–2026)
11.7.5 Glycostem Therapeutics Recent Development
11.8 Dragonfly Therapeutics
11.8.1 Dragonfly Therapeutics Company Details
11.8.2 Dragonfly Therapeutics Business Overview
11.8.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.8.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2021–2026)
11.8.5 Dragonfly Therapeutics Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Details
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2021–2026)
11.9.5 Nkarta Therapeutics Recent Development
11.10 Fortress Biotech
11.10.1 Fortress Biotech Company Details
11.10.2 Fortress Biotech Business Overview
11.10.3 Fortress Biotech NK Cell Therapy Introduction
11.10.4 Fortress Biotech Revenue in NK Cell Therapy Business (2021–2026)
11.10.5 Fortress Biotech Recent Development
11.11 Nkure
11.11.1 Nkure Company Details
11.11.2 Nkure Business Overview
11.11.3 Nkure NK Cell Therapy Introduction
11.11.4 Nkure Revenue in NK Cell Therapy Business (2021–2026)
11.11.5 Nkure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of NK Cell Therapy
 Table 3. Key Players of CAR-NK Cell Therapy
 Table 4. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global NK Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global NK Cell Therapy Market Share by Region (2021–2026)
 Table 8. Global NK Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global NK Cell Therapy Market Share by Region (2027–2032)
 Table 10. NK Cell Therapy Market Trends
 Table 11. NK Cell Therapy Market Drivers
 Table 12. NK Cell Therapy Market Challenges
 Table 13. NK Cell Therapy Market Restraints
 Table 14. Global NK Cell Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global NK Cell Therapy Market Share by Players (2021–2026)
 Table 16. Global Top NK Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on NK Cell Therapy Revenue, 2025
 Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of NK Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of NK Cell Therapy, Products and Applications
 Table 21. Global Key Players of NK Cell Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global NK Cell Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global NK Cell Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global NK Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global NK Cell Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global NK Cell Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global NK Cell Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global NK Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global NK Cell Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America NK Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America NK Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe NK Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe NK Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific NK Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific NK Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific NK Cell Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America NK Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America NK Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa NK Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa NK Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa NK Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. Nektar Therapeutics Company Details
 Table 47. Nektar Therapeutics Business Overview
 Table 48. Nektar Therapeutics NK Cell Therapy Product
 Table 49. Nektar Therapeutics Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 50. Nektar Therapeutics Recent Development
 Table 51. ImmunityBio, Inc Company Details
 Table 52. ImmunityBio, Inc Business Overview
 Table 53. ImmunityBio, Inc NK Cell Therapy Product
 Table 54. ImmunityBio, Inc Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 55. ImmunityBio, Inc Recent Development
 Table 56. GC Cell Company Details
 Table 57. GC Cell Business Overview
 Table 58. GC Cell NK Cell Therapy Product
 Table 59. GC Cell Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 60. GC Cell Recent Development
 Table 61. Affimed Company Details
 Table 62. Affimed Business Overview
 Table 63. Affimed NK Cell Therapy Product
 Table 64. Affimed Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 65. Affimed Recent Development
 Table 66. Innate Pharma SA Company Details
 Table 67. Innate Pharma SA Business Overview
 Table 68. Innate Pharma SA NK Cell Therapy Product
 Table 69. Innate Pharma SA Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 70. Innate Pharma SA Recent Development
 Table 71. Fate Therapeutics Company Details
 Table 72. Fate Therapeutics Business Overview
 Table 73. Fate Therapeutics NK Cell Therapy Product
 Table 74. Fate Therapeutics Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 75. Fate Therapeutics Recent Development
 Table 76. Glycostem Therapeutics Company Details
 Table 77. Glycostem Therapeutics Business Overview
 Table 78. Glycostem Therapeutics NK Cell Therapy Product
 Table 79. Glycostem Therapeutics Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 80. Glycostem Therapeutics Recent Development
 Table 81. Dragonfly Therapeutics Company Details
 Table 82. Dragonfly Therapeutics Business Overview
 Table 83. Dragonfly Therapeutics NK Cell Therapy Product
 Table 84. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 85. Dragonfly Therapeutics Recent Development
 Table 86. Nkarta Therapeutics Company Details
 Table 87. Nkarta Therapeutics Business Overview
 Table 88. Nkarta Therapeutics NK Cell Therapy Product
 Table 89. Nkarta Therapeutics Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 90. Nkarta Therapeutics Recent Development
 Table 91. Fortress Biotech Company Details
 Table 92. Fortress Biotech Business Overview
 Table 93. Fortress Biotech NK Cell Therapy Product
 Table 94. Fortress Biotech Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 95. Fortress Biotech Recent Development
 Table 96. Nkure Company Details
 Table 97. Nkure Business Overview
 Table 98. Nkure NK Cell Therapy Product
 Table 99. Nkure Revenue in NK Cell Therapy Business (US$ Million), 2021–2026
 Table 100. Nkure Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. NK Cell Therapy Picture
 Figure 2. Global NK Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global NK Cell Therapy Market Share by Type: 2025 vs 2032
 Figure 4. NK Cell Therapy Features
 Figure 5. CAR-NK Cell Therapy Features
 Figure 6. Global NK Cell Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global NK Cell Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Cancer Case Studies
 Figure 9. Infectious Diseases Case Studies
 Figure 10. Gastrointestinal Diseases Case Studies
 Figure 11. Beauty and Anti-Aging Case Studies
 Figure 12. Others Case Studies
 Figure 13. NK Cell Therapy Report Years Considered
 Figure 14. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global NK Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global NK Cell Therapy Market Share by Region: 2025 vs 2032
 Figure 17. Global NK Cell Therapy Market Share by Players in 2025
 Figure 18. Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2025
 Figure 20. North America NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America NK Cell Therapy Market Share by Country (2021–2032)
 Figure 22. United States NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe NK Cell Therapy Market Share by Country (2021–2032)
 Figure 26. Germany NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific NK Cell Therapy Market Share by Region (2021–2032)
 Figure 34. China NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America NK Cell Therapy Market Share by Country (2021–2032)
 Figure 42. Mexico NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa NK Cell Therapy Market Share by Country (2021–2032)
 Figure 46. Israel NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE NK Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 50. ImmunityBio, Inc Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 51. GC Cell Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 52. Affimed Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 53. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 54. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 55. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 56. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 57. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 58. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 59. Nkure Revenue Growth Rate in NK Cell Therapy Business (2021–2026)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture